Aristea [Air-is-tay-uh] is derived from the Greek word aristeia, which refers to a scene typical of epic poetry in which the hero reaches his or her peak as a fighter; it also derives from the root aristos, meaning “best of everything.” We aim to live up to the mythic origins of our name as we develop immunology-focused therapeutics to treat autoimmune and inflammatory diseases.


Aristea Therapeutics’ mission is to address the significant unmet medical needs of people living with autoimmune inflammatory diseases.

Through our passionate pursuit of excellence in medicine, we are dedicated to developing new therapeutics and helping improve the lives of patients.


Passionnoun | \pa-shǝn\

: a strong feeling of enthusiasm or excitement for something or about doing something

Focusnoun | \fō-kǝs\

: a center of activity, attraction, or attention

Agilitynoun | \ǝ-‘ji-lǝ-tē\

: the power of moving quickly and easily; nimbleness

Diligence – noun | \di-lǝ-jǝn(ts)\

: steady, earnest, and energetic effort : devoted and painstaking work and application to accomplish an undertaking

Compassion – noun | \kǝm-‘pa-shǝn\

: sympathetic consciousness of others’ distress together with a desire to alleviate it


James Mackay, Ph.D.

President & CEO

Nihar Bhakta, M.D.

Chief Medical Officer

Dr. Himanshu Patel, D.O.

Executive Medical Director

Stacy Anthony

Senior Director,
Clinical Operations

DeAnne Reid

Senior Director, Operations & Business Development

Tracy Rodgers

Senior Director,
Clinical Operations

Sara McCutchan

Director, Regulatory & Quality


Ciara Kennedy

Independent Board Chair

Kenneth Harrison

Partner, Novo Ventures

Loretta Tse

VP, Tekla Capital Management LLC

James Mackay

President & CEO

Daniel O’Connell

Partner at Novo Ventures

Mark Gergen

Independent Board Member

Michael S. Vincent

Board Observer

Tyrell Rivers

Board Observer